BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1412 related articles for article (PubMed ID: 29080197)

  • 21. hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer.
    Chen Y; Jiang T; Shi L; He K
    Med Oncol; 2016 Jan; 33(1):3. PubMed ID: 26607374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
    Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
    Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/β-catenin signaling pathway is involved in regulating the migration by an effective natural compound brucine in LoVo cells.
    Shi X; Zhu M; Kang Y; Yang T; Chen X; Zhang Y
    Phytomedicine; 2018 Jul; 46():85-92. PubMed ID: 30097126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway.
    Tong X; Zhuang Z; Wang X; Yang X; Bai L; Su L; Wei P; Su X
    Biomed Pharmacother; 2021 May; 137():111209. PubMed ID: 33581651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
    Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
    Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway.
    Zheng R; Deng Q; Liu Y; Zhao P
    Med Sci Monit; 2017 Jan; 23():163-171. PubMed ID: 28077837
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Jin Y; Chen W; Yang H; Yan Z; Lai Z; Feng J; Peng J; Lin J
    Exp Ther Med; 2017 Dec; 14(6):5527-5534. PubMed ID: 29285087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
    Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
    Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
    Huang GM; Sun Y; Ge X; Wan X; Li CB
    World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
    Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
    Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
    J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gynura divaricata attenuates tumor growth and tumor relapse after cisplatin therapy in HCC xenograft model through suppression of cancer stem cell growth and Wnt/β-catenin signalling.
    Yen CH; Lai CC; Shia TH; Chen M; Yu HC; Liu YP; Chang FR
    J Ethnopharmacol; 2018 Mar; 213():366-375. PubMed ID: 28729225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nigericin Exerts Anticancer Effects on Human Colorectal Cancer Cells by Inhibiting Wnt/β-catenin Signaling Pathway.
    Liu F; Li W; Hua S; Han Y; Xu Z; Wan D; Wang Y; Chen W; Kuang Y; Shi J; Zhi Q
    Mol Cancer Ther; 2018 May; 17(5):952-965. PubMed ID: 29483216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo.
    Choi IK; Kim YH; Kim JS; Seo JH
    Invest New Drugs; 2008 Jun; 26(3):283-8. PubMed ID: 18161004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.